Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Iron-Tannic Acid Hydrogel Mediated Mild Photothermal Therapy Combined With Ferroptosis Enhances Anti-Tumor Immunity in Colorectal Cancer.

Created on 25 Aug 2026

Authors

Yuan Zhu, Xi Yu, Tao Wang, Wanyi Liu, Chang Lu, Jiani Zhong, Yujie He, Wei Li, Kunxi Zhang, Peihao Yin, Zeting Yuan

Published in

Advanced science (Weinheim, Baden-Wurttemberg, Germany). Pages e77186. Aug 25, 2026. Epub Aug 25, 2026.

Abstract

Postoperative recurrence and metastasis are the primary causes of mortality in colorectal cancer (CRC). And its immunosuppressive tumor microenvironment (TME) often results in the poor response to immune checkpoint blockade (ICB). This study designed an injectable and adhesive tannic acid-iron hydrogel for locally mild photothermal therapy (PTT, ≤ 45°C) and ferroptosis to prevent the postoperative recurrence and metastasis in combination with programmed death ligand 1 (PD-L1) checkpoint blockade immunotherapy. First, this system was assembled from tannic acid (TA) and gelatin microspheres to form an injectable and adhesive hydrogel (Gel/TA). Subsequently, the metal-polyphenol network (MPNs) was introduced via Fe3+-TA interactions, providing photothermal conversion and Fe3+ release capabilities (Gel/TA/Fe3+). Gel/TA/Fe3+ hydrogels not only ablated tumor cells and induced immunogenic cell death (ICD) under near-infrared (NIR) irradiation, but also elicited ferroptosis of both tumor cells and tumor-associated macrophage (TAMs), resulting in dendritic cells (DCs) maturation, T-cell infiltration and down-regulation of ferroptosis-sensitive M2-type TAMs levels. Therefore, in cooperation with αPD-L1, Gel/TA/Fe3+ could not only evoke an immune response against the primary tumor, but also promote an abscopal effect against distant metastatic tumor. This work presented a novel material for CRC postoperative therapy via the synergistic effect of immediate tumor-cell killing and enhanced immunotherapy.

PMID:
42640115
Bibliographic data and abstract were imported from PubMed on 25 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement